Found: 37
Select item for more details and to access through your institution.
Spotlight on the utility of the Oncotype DX® breast cancer assay.
- Published in:
- International Journal of Women's Health, 2018, v. 10, p. 89, doi. 10.2147/IJWH.S124520
- By:
- Publication type:
- Article
Rising to the challenge: Qualitative assessment of medical student perceptions responding to the COVID-19 pandemic.
- Published in:
- Clinical Medicine, 2020, v. 20, n. 6, p. e244, doi. 10.7861/clinmed.2020-0219
- By:
- Publication type:
- Article
Clinical Controversies in Breast Cancer: A Thought Leader Forum and Consensus Roundtable.
- Published in:
- Asia Pacific Journal of Oncology & Hematology, 2009, v. 1, n. 3, p. 47
- By:
- Publication type:
- Article
Male Breast Cancer: A Review.
- Published in:
- Asia Pacific Journal of Oncology & Hematology, 2009, v. 1, n. 1, p. 19
- By:
- Publication type:
- Article
Visualization of Germination Proteins in Putative Bacillus cereus Germinosomes.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5198, doi. 10.3390/ijms21155198
- By:
- Publication type:
- Article
Uptake of adjuvant breast cancer treatments recommended by multi‐disciplinary meetings.
- Published in:
- ANZ Journal of Surgery, 2018, v. 88, n. 7/8, p. 745, doi. 10.1111/ans.14368
- By:
- Publication type:
- Article
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 1, p. 67, doi. 10.1007/s10549-022-06856-1
- By:
- Publication type:
- Article
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 3, p. 67, doi. 10.1007/s10549-022-06856-1
- By:
- Publication type:
- Article
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 87, doi. 10.1007/s10549-020-05825-w
- By:
- Publication type:
- Article
RodZ and PgsA Play Intertwined Roles in Membrane Homeostasis of Bacillus subtilis and Resistance to Weak Organic Acid Stress.
- Published in:
- Frontiers in Microbiology, 2016, v. 7, p. 1, doi. 10.3389/fmicb.2016.01633
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8179, doi. 10.2147/CMAR.S325043
- By:
- Publication type:
- Article
Incidence, clinical implications and impact on public health of infections with Shigella spp. and entero-invasive Escherichia coli (EIEC): results of a multicenter cross-sectional study in the Netherlands during 2016-2017.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High Detection Rates of Enteropathogens in Asymptomatic Children Attending Day Care.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089496
- By:
- Publication type:
- Article
The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer.
- Published in:
- Medical Journal of Australia, 2013, v. 199, n. 3, p. 205, doi. 10.5694/mja12.11334
- By:
- Publication type:
- Article
Pain outcomes in patients with advanced breast cancer and bone metastases.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 4, p. 832, doi. 10.1002/cncr.27789
- By:
- Publication type:
- Article
Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2‐non‐amplified metastatic breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, p. 12, doi. 10.1111/ajco.13065
- By:
- Publication type:
- Article
Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, p. 3, doi. 10.1111/ajco.13064
- By:
- Publication type:
- Article
Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, p. 19, doi. 10.1111/ajco.12492
- By:
- Publication type:
- Article
Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, p. 3, doi. 10.1111/ajco.12491
- By:
- Publication type:
- Article
Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, n. 4, p. 368, doi. 10.1111/ajco.12292
- By:
- Publication type:
- Article
Systemic treatment of HER2-positive metastatic breast cancer: A systematic review.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, p. 1, doi. 10.1111/ajco.12206
- By:
- Publication type:
- Article
Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, p. 15, doi. 10.1111/ajco.12207
- By:
- Publication type:
- Article
Use of non-anthracycline regimens in early stage breast cancer in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 1, p. 4, doi. 10.1111/j.1743-7563.2010.01353.x
- By:
- Publication type:
- Article
Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2-positive breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2009, v. 5, n. 1, p. 4, doi. 10.1111/j.1743-7563.2009.01194.x
- By:
- Publication type:
- Article
Male breast cancer: Progress, prognosis and future pathways.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2008, v. 4, n. 1, p. 6, doi. 10.1111/j.1743-7563.2008.00141.x
- By:
- Publication type:
- Article
Cancer treatment-induced bone loss: A review.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2006, v. 2, n. 4, p. 156, doi. 10.1111/j.1743-7563.2006.00067.x
- By:
- Publication type:
- Article
Demonstrating the feasibility of collecting secondary, de‐identified data on Australian patients receiving treatment as part of a Medicine Access Programme.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 1, p. 99, doi. 10.1111/imj.14265
- By:
- Publication type:
- Article
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.
- Published in:
- Internal Medicine Journal, 2018, v. 48, n. 1, p. 37, doi. 10.1111/imj.13491
- By:
- Publication type:
- Article
Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 9, p. 2563, doi. 10.1245/s10434-018-6469-7
- By:
- Publication type:
- Article
Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals' attitudes to and experience with scalp cooling.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA).
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 2, p. 267, doi. 10.1002/ijc.34245
- By:
- Publication type:
- Article
Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer.
- Published in:
- OncoTargets & Therapy, 2013, v. 6, p. 1, doi. 10.2147/OTT.S27671
- By:
- Publication type:
- Article
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biocompatible and Biodegradable Magnesium Oxide Nanoparticles with In Vitro Photostable Near-Infrared Emission: Short-Term Fluorescent Markers.
- Published in:
- Nanomaterials (2079-4991), 2019, v. 9, n. 10, p. 1360, doi. 10.3390/nano9101360
- By:
- Publication type:
- Article
Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0126220
- By:
- Publication type:
- Article